Manual screening of medical literature is one of the most...
DrugCard’s CEO Dmytro Horilyk Featured in Founder Story Interview: The Journey Behind Building an AI-Powered PV Platform
Our CEO and co-founder, Dmytro Horilyk, was recently featured in...
AI Features on the DrugCard Platform: How Artificial Intelligence Supports Pharmacovigilance Literature Screening
Pharmacovigilance teams process large volumes of literature every week: case...
Shaping the Future of Pharmacovigilance: What We Took Away Together
On June 4, 2026, over 80 pharmacovigilance professionals joined DrugCard...
Shaping the Future of Pharmacovigilance: Leadership, Communication & Community | DrugCard Webinar
Online Webinar | June 4, 2026 | 13:00 CEST Pharmacovigilance...
DrugCard Joins EUCROF as an Associate Member
We are excited to announce that DrugCard has officially joined...
DrugCard Announces Acquisition of SIA OOM to Strengthen Pharmacovigilance Presence in the Baltics
TALLINN, ESTONIA/RIGA, LATVIA – April 21, 2026 – DrugCards OÜ...
The Second Kyiv Drug Safety Day: Leadership and Communication in Pharmacovigilance: The Role of Everyone
On April 16, 2026, we held the second Kyiv Drug...
How NOT to Buy AI for Pharmacovigilance: Insights from a Talk by Our CEO, Dmytro Horilyk
At the European Drug Safety & AI Conference 2026, DrugCard...
